• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Time to recurrence, but not recurrence-free survival, should be the endpoint used to predict early recurrence after HCC resection.

作者信息

Yan Wen-Tao, Quan Bing, Xing Hao, Wu Meng-Chao, Yang Tian

机构信息

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China; Department of Clinical Medicine, Navy Medical University, Shanghai 200433, China.

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.

出版信息

J Hepatol. 2019 Mar;70(3):570-571. doi: 10.1016/j.jhep.2018.10.025. Epub 2018 Dec 13.

DOI:10.1016/j.jhep.2018.10.025
PMID:30553526
Abstract
摘要

相似文献

1
Time to recurrence, but not recurrence-free survival, should be the endpoint used to predict early recurrence after HCC resection.复发时间而非无复发生存期，应作为预测肝癌切除术后早期复发的终点指标。
J Hepatol. 2019 Mar;70(3):570-571. doi: 10.1016/j.jhep.2018.10.025. Epub 2018 Dec 13.
2
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.米兰标准以外的肝细胞癌的外科治疗。肝切除、挽救性移植和原位肝移植的结果。
Ann Surg Oncol. 2008 May;15(5):1383-91. doi: 10.1245/s10434-008-9851-z. Epub 2008 Mar 5.
3
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.复发性肝细胞癌患者再次肝切除术的选择标准。
Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6.
4
Commentary on: "Dynamic liver function is an independent predictor of recurrence-free survival after curative liver resection for HCC - a retrospective cohort study".关于《动态肝功能是肝癌根治性肝切除术后无复发生存的独立预测因素——一项回顾性队列研究》的评论
Int J Surg. 2019 Nov;71:168. doi: 10.1016/j.ijsu.2019.09.027. Epub 2019 Sep 28.
5
Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.复发性肝细胞癌患者挽救性肝移植的可行性
Clin Transplant. 2005 Apr;19(2):175-80. doi: 10.1111/j.1399-0012.2005.00277.x.
6
Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma.多灶性肝细胞癌肝切除术后及后续多模式治疗复发的结果。
Br J Surg. 2013 Oct;100(11):1516-22. doi: 10.1002/bjs.9263.
7
Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.频繁局部消融治疗对肝癌肝切除术后肝内复发患者长期生存的影响：一项对610例16岁以上患者的分析
Ann Surg. 2006 Aug;244(2):265-73. doi: 10.1097/01.sla.0000217921.28563.55.
8
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
9
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.肝细胞癌肝切除术后复发：危险因素、治疗及预后
Surgery. 2007 Mar;141(3):330-9. doi: 10.1016/j.surg.2006.06.028. Epub 2006 Nov 1.
10
Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma.肝切除术后复发的肝细胞癌，再次肝切除术是最有效的治疗方法。
J Hepatobiliary Pancreat Surg. 2001;8(5):410-6. doi: 10.1007/s005340100002.

引用本文的文献

1
Clinical significance of the preoperative prognostic nutritional index in patients with resectable non-small cell lung cancer: a multicenter study.可切除非小细胞肺癌患者术前预后营养指数的临床意义：一项多中心研究
Surg Today. 2025 Jan 16. doi: 10.1007/s00595-024-02987-8.
2
Do low skeletal muscle bulk and disturbed body fat mass impact tumor recurrence in stage I/II hepatocellular carcinoma undergoing surgery? An observational cohort study.低骨骼肌量和紊乱的体脂质量会影响接受手术的I/II期肝细胞癌患者的肿瘤复发吗？一项观察性队列研究。
Int J Surg. 2024 Nov 1;110(11):7067-7079. doi: 10.1097/JS9.0000000000001905.
3
Small graft size and hepatocellular carcinoma outcomes in living donor liver transplantation: a retrospective multicentric cohort study.
小移植物体积与活体肝移植后肝细胞癌结局：一项回顾性多中心队列研究。
Int J Surg. 2024 Aug 1;110(8):4859-4866. doi: 10.1097/JS9.0000000000001532.
4
The Role of PIVKA-II as a Predictor of Early Hepatocellular Carcinoma Recurrence-Free Survival after Liver Transplantation in a Low Alpha-Fetoprotein Population.在低甲胎蛋白人群中，异常凝血酶原-II作为肝移植后早期肝细胞癌无复发生存预测指标的作用
Cancers (Basel). 2023 Dec 19;16(1):4. doi: 10.3390/cancers16010004.
5
Differences in Colorectal Cancer Survival Based on Primary Tumor Location: Retrospective Study from a Single Institution.基于原发性肿瘤位置的结直肠癌生存率差异：来自单一机构的回顾性研究
J Cancer. 2023 Aug 6;14(13):2444-2454. doi: 10.7150/jca.85695. eCollection 2023.
6
Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation.包裹肿瘤团块的血管与血管模式和肝移植后肝细胞癌复发之间的关联。
Front Oncol. 2022 Oct 26;12:997093. doi: 10.3389/fonc.2022.997093. eCollection 2022.
7
Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.预测根治性肝切除术后肝细胞癌早期和晚期复发的新型预后列线图
Cancer Manag Res. 2020 Mar 9;12:1693-1712. doi: 10.2147/CMAR.S241959. eCollection 2020.
8
Hepatocellular carcinoma - time to take the ticket.肝细胞癌——是时候采取行动了。
World J Gastrointest Surg. 2019 Jun 27;11(6):287-295. doi: 10.4240/wjgs.v11.i6.287.